InnovAge Holding Corp. (INNV)
USD 3.15
(5.7%)
USD 3.15
(5.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 113.03 Million USD | 3.86% |
| 2023 | 108.83 Million USD | 28.32% |
| 2022 | 84.81 Million USD | 2.64% |
| 2021 | 82.63 Million USD | -62.09% |
| 2020 | 217.95 Million USD | 11.9% |
| 2019 | 194.77 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 113.03 Million USD | 0.99% |
| 2024 Q3 | 111.93 Million USD | -0.47% |
| 2024 Q2 | 112.45 Million USD | 5.97% |
| 2024 FY | 113.03 Million USD | 3.86% |
| 2024 Q1 | 106.11 Million USD | -2.5% |
| 2023 Q3 | 111.32 Million USD | 4.34% |
| 2023 Q2 | 106.68 Million USD | -0.73% |
| 2023 FY | 108.83 Million USD | 28.32% |
| 2023 Q1 | 107.47 Million USD | 26.72% |
| 2023 Q4 | 108.83 Million USD | -2.23% |
| 2022 Q2 | 85.32 Million USD | 4.8% |
| 2022 Q4 | 84.81 Million USD | -1.77% |
| 2022 Q3 | 86.34 Million USD | 1.19% |
| 2022 Q1 | 81.41 Million USD | -1.47% |
| 2022 FY | 84.81 Million USD | 2.64% |
| 2021 Q2 | 301.18 Million USD | 0.0% |
| 2021 FY | 82.63 Million USD | -62.09% |
| 2021 Q4 | 82.63 Million USD | -0.58% |
| 2021 Q3 | 83.11 Million USD | -72.4% |
| 2020 Q4 | 217.95 Million USD | 0.0% |
| 2020 FY | 217.95 Million USD | 11.9% |
| 2019 FY | 194.77 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 92.518% |
| Addus HomeCare Corporation | 175.18 Million USD | 35.476% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -13.412% |
| Amedisys, Inc. | 487.21 Million USD | 76.8% |
| Astrana Health, Inc. | 321.01 Million USD | 64.788% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 92.46% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | 1.598% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -937.396% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -2046.098% |
| COMPASS Pathways plc | 33.04 Million USD | -242.012% |
| DocGo Inc. | 46.49 Million USD | -143.101% |
| The Ensign Group, Inc. | 1.87 Billion USD | 93.96% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -159.047% |
| The Joint Corp. | 16.73 Million USD | -575.447% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 77.881% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -17101.236% |
| ModivCare Inc. | 1.14 Billion USD | 90.085% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -33890.071% |
| Option Care Health, Inc. | 1.16 Billion USD | 90.309% |
| P3 Health Partners Inc. | 124.64 Million USD | 9.312% |
| P3 Health Partners Inc. | 124.64 Million USD | 9.312% |
| The Pennant Group, Inc. | 329.63 Million USD | 65.709% |
| Surgery Partners, Inc. | 3.06 Billion USD | 96.308% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -45459.707% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 5.659% |
| The Oncology Institute, Inc. | 119.81 Million USD | 5.659% |